These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2435716

  • 1. Monoclonal antibody Leo Mel 3, which inhibits killing of human melanoma cells by anomalous killer cells, binds to a sugar sequence in GD2 (II3(NeuAc)2-GgOse3Cer) and several other gangliosides.
    Fukuta S, Werkmeister JA, Burns GF, Ginsburg V, Magnani JL.
    J Biol Chem; 1987 Apr 05; 262(10):4800-3. PubMed ID: 2435716
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
    Furukawa K, Yamaguchi H, Oettgen HF, Old LJ, Lloyd KO.
    Cancer Res; 1989 Jan 01; 49(1):191-6. PubMed ID: 2908845
    [Abstract] [Full Text] [Related]

  • 5. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
    Vrionis FD, Wikstrand CJ, Fredman P, Månsson JE, Svennerholm L, Bigner DD.
    Cancer Res; 1989 Dec 01; 49(23):6645-51. PubMed ID: 2479468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells.
    Kawashima I, Kotani M, Ozawa H, Suzuki M, Tai T.
    Int J Cancer; 1994 Jul 15; 58(2):263-8. PubMed ID: 8026889
    [Abstract] [Full Text] [Related]

  • 8. GD3 expression by cultured human tumor cells of neuroectodermal origin.
    He X, Wikstrand CJ, Fredman P, Månsson JE, Svennerholm L, Bigner DD.
    Acta Neuropathol; 1989 Jul 15; 79(3):317-25. PubMed ID: 2609939
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of a structure on human melanoma cells recognized by CTL exhibiting anomalous killer cell function.
    Werkmeister JA, Triglia T, Andrews P, Burns GF.
    J Immunol; 1985 Jul 15; 135(1):689-95. PubMed ID: 3873498
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathy.
    Brindel I, Preud'homme JL, Vallat JM, Vincent D, Vasquez JL, Jauberteau MO.
    Neurosci Lett; 1994 Nov 07; 181(1-2):103-6. PubMed ID: 7534889
    [Abstract] [Full Text] [Related]

  • 12. Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas.
    Hirabayashi Y, Higashi H, Kato S, Taniguchi M, Matsumoto M.
    Jpn J Cancer Res; 1987 Jun 07; 78(6):614-20. PubMed ID: 3112076
    [Abstract] [Full Text] [Related]

  • 13. Cell surface reactive human monoclonal antibody directed to human melanoma-associated gangliosides.
    Abdel-Wahab Z, Li WP, Darrow T, Nudelman ED, Towell A, Seigler HF.
    Melanoma Res; 1993 Dec 07; 3(6):415-23. PubMed ID: 8161881
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma.
    Hirabayashi Y, Hamaoka A, Matsumoto M, Matsubara T, Tagawa M, Wakabayashi S, Taniguchi M.
    J Biol Chem; 1985 Oct 25; 260(24):13328-33. PubMed ID: 2414279
    [Abstract] [Full Text] [Related]

  • 18. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
    Hiraiwa N, Tsuyuoka K, Li YT, Tanaka M, Seno T, Okubo Y, Fukuda Y, Imura H, Kannagi R.
    Cancer Res; 1990 Sep 01; 50(17):5497-503. PubMed ID: 2167157
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.